Startseite>>D-myo-Inositol-1-phosphate (cyclohexyl ammonium salt)

D-myo-Inositol-1-phosphate (cyclohexyl ammonium salt) (Synonyms: Ins(1)P1 (cyclohexyl ammonium salt), 1IP1 (cyclohexyl ammonium salt))

Katalog-Nr.GC43528

D-myo-Inositol-1-phosphate (Ins(1)P1) is a member of the inositol phosphate molecular family of second messengers that play critical roles in intracellular signaling.

Products are for research use only. Not for human use. We do not sell to patients.

D-myo-Inositol-1-phosphate (cyclohexyl ammonium salt) Chemische Struktur

Größe Preis Lagerbestand Menge
500μg
52,00 $
Auf Lager
1mg
98,00 $
Auf Lager
5mg
411,00 $
Auf Lager
10mg
720,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

D-myo-Inositol-1-phosphate (Ins(1)P1) is a member of the inositol phosphate molecular family of second messengers that play critical roles in intracellular signaling. Ins(1)P1 can be formed by PLC hydrolysis of phosphatidylinositol or by dephosphorylation of polyphosphate inositols such as Ins(1,3)P2 by inositol polyphosphate 3-phosphatase. Changes in myo-inositol-1-phosphate synthase activity and inositol levels are induced by lithium and valproate and are associated with bipolar disorder. Also, cross-regulation occurs between the SUMO and inositol pathways.

Bewertungen

Review for D-myo-Inositol-1-phosphate (cyclohexyl ammonium salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 15 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for D-myo-Inositol-1-phosphate (cyclohexyl ammonium salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.